John Richard Baker

This inventor holds 11 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Protemix Corporation Limited, Philera New Zealand Limited, Other. Active years: 1987-2015.

USPTO Granted Patents = 11

% Patents Active = 54.5

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 1.5

ph-index = 7

Forward Citations = 151(Granted Patents)

Company Filing History:

5 out of 8

Protemix Corporation Limited

patents

4 out of 14

Philera New Zealand Limited

patents

2 out of 834,411

Other

patents

Years Active: 1987-2015

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8987244 - Preventing and/or treating cardiovascular disease and/or associated heart failure (2015-03-24),

2. 8563538 - Preventing and/or treating cardiovascular disease and/or associated heart failure (2013-10-22),

3. 8034799 - Preventing and/or treating cardiovascular disease and/or associated heart failure (2011-10-11),

4. 7928094 - Treatment of diabetes with copper binding compounds (2011-04-19),

5. 7459446 - Treatment of diabetes with copper binding compounds (2008-12-02),

6. 6951890 - Preventing and/or treating cardiovascular disease and/or associated heart failure (2005-10-04),

7. 6897243 - Fructosamine oxidase: antagonists and inhibitors (2005-05-24),

8. 6855511 - Fructosamine oxidase assay: methods and materials (2005-02-15),

9. 6610693 - Fructosamine oxidase: antagonists and inhibitors (2003-08-26),

10. 6348465 - Fructosamine oxidase: antagonists and inhibitors (2002-02-19),

11. 4645742 - Materials for determining fructosamine levels in blood samples (1987-02-24),

Title: John Richard Baker: Innovator in Cardiovascular Health

Introduction

John Richard Baker is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of cardiovascular health, holding a total of 11 patents. His work focuses on innovative methods for preventing and treating cardiovascular diseases and associated heart failure.

Latest Patents

Baker's latest patents include methods for reducing copper values to treat, prevent, or ameliorate tissue damage caused by various heart muscle disorders. These disorders include cardiomyopathy and myocarditis, as well as atheromatous disorders affecting major blood vessels. His patents also address complications arising from diabetes and other metabolic conditions that impact small blood vessels.

Career Highlights

Throughout his career, John Richard Baker has worked with several companies, including Protemix Corporation Limited and Philera New Zealand Limited. His expertise in cardiovascular health has positioned him as a key figure in the development of innovative treatments.

Collaborations

Baker has collaborated with notable individuals in his field, including Garth J S Cooper and Garth James Cooper. These partnerships have furthered his research and development efforts in cardiovascular health.

Conclusion

John Richard Baker's contributions to cardiovascular health through his patents and collaborations highlight his commitment to innovation in medical science. His work continues to impact the treatment and prevention of heart-related diseases.